We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ELEV market cap is 180.01M. The company's latest EPS is USD -0.9394 and P/E is -3.94.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.53M | -18.54M | -16.75M | -9.83M | -10.92M |
| Net Income | -38.84M | -19.04M | -17.06M | -10.11M | -10.64M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -32.05M | -94.55M | -45.45M |
| Net Income | -32.04M | -95.08M | -45.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 111.49M | 94.16M | 76.9M | 110.37M | 99.98M |
| Total Liabilities | 44.37M | 45.13M | 43.13M | 38.19M | 37.56M |
| Total Equity | 67.12M | 49.03M | 33.76M | 72.18M | 62.42M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 149.49M | 94.16M | 89.09M |
| Total Liabilities | 8.8M | 45.13M | 34.28M |
| Total Equity | 140.7M | 49.03M | 54.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -67.63M | -85.48M | -16.83M | -30.64M | -44M |
| Investing | -55.58M | -44.4M | 26.6M | 43.1M | 4.98M |
| Financing | 29.52M | 29.51M | 216k | 47.95M | 47.98M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.17M | -85.48M | -56.18M |
| Investing | N/A | -44.4M | 11.54M |
| Financing | 97.05M | 29.51M | 47.98M |
| Market Cap | 180.01M |
| Price to Earnings Ratio | -3.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.65 |
| Price to Book Ratio | 3.28 |
| Dividend Yield | - |
| Shares Outstanding | 48.65M |
| Average Volume (1 week) | 1.63M |
| Average Volume (1 Month) | 879.86k |
| 52 Week Change | 12.12% |
| 52 Week High | 5.89 |
| 52 Week Low | 0.363 |
| Spread (Intraday) | 0.74 (18.41%) |
| Company Name | Elevation Oncology Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.elevationoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
